Dong Sung Pharmaceutical Files to Terminate Rehabilitation: Normalization After 160 Billion Won Investment

Filed for termination of rehabilitation proceedings with Seoul Bankruptcy Court on May 6, 2026.
Court approved rehabilitation plan on March 27, 2026.
Raised total 160 billion won: 70 billion won via rights offering, 90 billion won via bond issuance.
Completed repayment as of April 30, 2026 using funds raised, with court permission.
Operational normalization: amended articles of incorporation, capital change registration, appointment of new executives.
Pending Korea Exchange listing resumption review after rehabilitation termination.